Sept. 4 Financial Quick Takes: BrightGene looks to STAR; plus IPO updates from Immunotech, 10x Genomics, SpringWorks, IGM, Satsuma and more

BrightGene advances toward STAR market
The Shanghai Stock Exchange approved an application from BrightGene Bio-Medical Technology Co. Ltd. (Suzhou, China) to raise RMB360 million ($50.3 million) in a listing on its STAR market. If the China Securities Regulatory Commission decides to register the application, BrightGene could become the second biopharma to list on the market. The company is developing drugs for cancer and

Read the full 637 word article

User Sign In